Blog

Key TakeawaysTirzepatide fatigue affects up to 7% of users and is most pronounced during dose escalation, typically resolving within 2

Key Takeaways: Both drugs cause similar GI side effects (nausea, diarrhoea, vomiting), but data from the SURMOUNT-5 trial suggest tirzepatide

Key Takeaways •  Three approved sites: Tirzepatide may be injected into the abdomen, outer thigh, or upper arm. Each site

Last reviewed: May 2026  |  Reviewed against current FDA labeling and 2024-2025 cohort data Key TakeawaysThe black box warning on

Key Takeaways: GLP-1 nausea is one of the most common side effects and occurs because these medications slow down how

What the landmark SELECT trial, the FDA’s 2024 approval, and the latest cardiology evidence reveal about GLP-1 medications and your

Reviewed against multi-society clinical guidance | Last updated: May 2026 KEY TAKEAWAYSGLP-1 medicines slow stomach emptying as part of how

Key TakeawaysGLP-1 and GIP are gut hormones with different jobs. GLP-1 slows digestion and curbs appetite, while GIP improves insulin

Key Takeaways• GLP-1 brain receptors are spread across the hypothalamus, brainstem, and reward circuits, and they reduce both hunger and

Reviewed by [Endocrinologist Name, MD, DM Endocrinology]  |  Last updated: April 2026 Key TakeawaysGLP-1 drug labels list pancreatitis as a